$EXPO
EXPONENT INC

2013 Q3 Form 10-Q Financial Statement

#000114420413058283 Filed on November 01, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2012 Q3
Revenue $75.23M $73.30M
YoY Change 2.64% 11.14%
Cost Of Revenue $5.100M $6.600M
YoY Change -22.73% 46.67%
Gross Profit $70.10M $66.70M
YoY Change 5.1% 10.07%
Gross Profit Margin 93.18% 91.0%
Selling, General & Admin $48.50M $46.10M
YoY Change 5.21% 11.08%
% of Gross Profit 69.19% 69.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.300M $1.200M
YoY Change 8.33% 20.0%
% of Gross Profit 1.85% 1.8%
Operating Expenses $60.07M $58.57M
YoY Change 2.56% 18.5%
Operating Profit $15.16M $14.73M
YoY Change 2.93% -10.87%
Interest Expense $0.00 $100.0K
YoY Change -100.0%
% of Operating Profit 0.0% 0.68%
Other Income/Expense, Net $2.355M $1.602M
YoY Change 47.0% -175.42%
Pretax Income $17.52M $16.33M
YoY Change 7.26% 13.4%
Income Tax $6.421M $6.105M
% Of Pretax Income 36.66% 37.39%
Net Earnings $11.09M $10.23M
YoY Change 8.5% 16.94%
Net Earnings / Revenue 14.75% 13.95%
Basic Earnings Per Share $0.82 $0.75
Diluted Earnings Per Share $0.79 $0.72
COMMON SHARES
Basic Shares Outstanding 13.60M shares 13.69M shares
Diluted Shares Outstanding 13.99M shares 14.20M shares

Balance Sheet

Concept 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $135.0M $109.7M
YoY Change 23.06% 15.47%
Cash & Equivalents $121.7M $87.65M
Short-Term Investments $13.30M $22.10M
Other Short-Term Assets $17.80M $14.70M
YoY Change 21.09% -1.34%
Inventory $2.600M
Prepaid Expenses
Receivables $82.20M $88.36M
Other Receivables $0.00 $0.00
Total Short-Term Assets $235.0M $215.4M
YoY Change 9.09% 15.32%
LONG-TERM ASSETS
Property, Plant & Equipment $28.40M $27.18M
YoY Change 4.49% -1.88%
Goodwill $8.607M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $52.50M $833.0K
YoY Change 6202.52% -97.53%
Total Long-Term Assets $89.50M $78.16M
YoY Change 14.51% 11.65%
TOTAL ASSETS
Total Short-Term Assets $235.0M $215.4M
Total Long-Term Assets $89.50M $78.16M
Total Assets $324.5M $293.6M
YoY Change 10.53% 14.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.100M $10.20M
YoY Change -50.0% 15.91%
Accrued Expenses $47.60M $43.00M
YoY Change 10.7% 18.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $58.90M $58.55M
YoY Change 0.6% 17.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $34.90M $1.025M
YoY Change 3304.88% -95.38%
Total Long-Term Liabilities $34.90M $1.025M
YoY Change 3304.88% -95.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $58.90M $58.55M
Total Long-Term Liabilities $34.90M $1.025M
Total Liabilities $93.80M $85.44M
YoY Change 9.78% 18.34%
SHAREHOLDERS EQUITY
Retained Earnings $219.5M $198.8M
YoY Change 10.44%
Common Stock $121.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $111.9M
YoY Change
Treasury Stock Shares 3.240M shares
Shareholders Equity $230.6M $208.1M
YoY Change
Total Liabilities & Shareholders Equity $324.5M $293.6M
YoY Change 10.53% 14.32%

Cashflow Statement

Concept 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income $11.09M $10.23M
YoY Change 8.5% 16.94%
Depreciation, Depletion And Amortization $1.300M $1.200M
YoY Change 8.33% 20.0%
Cash From Operating Activities $17.40M $2.200M
YoY Change 690.91% -88.6%
INVESTING ACTIVITIES
Capital Expenditures $892.0K $1.483M
YoY Change -39.85% 52.73%
Acquisitions
YoY Change
Other Investing Activities -$6.900M $2.300M
YoY Change -400.0% -109.87%
Cash From Investing Activities -$7.800M $800.0K
YoY Change -1075.0% -103.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.200M -200.0K
YoY Change 2500.0% -98.72%
NET CHANGE
Cash From Operating Activities 17.40M 2.200M
Cash From Investing Activities -7.800M 800.0K
Cash From Financing Activities -5.200M -200.0K
Net Change In Cash 4.400M 2.800M
YoY Change 57.14% -113.73%
FREE CASH FLOW
Cash From Operating Activities $17.40M $2.200M
Capital Expenditures $892.0K $1.483M
Free Cash Flow $16.51M $717.0K
YoY Change 2202.37% -96.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
219493000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
206057000 USD
CY2013Q3 us-gaap Investment Income Net
InvestmentIncomeNet
14000 USD
CY2012Q3 us-gaap Investment Income Net
InvestmentIncomeNet
80000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
95000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
245000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87653000 USD
CY2006Q2 expo Authorized Preferred Stock Shares Limits On Use
AuthorizedPreferredStockSharesLimitsOnUse
2000000 shares
CY2013Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2013Q3 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
3000 USD
CY2013Q3 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
-6000 USD
CY2012 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
41000 USD
CY2012 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
-1000 USD
CY2006Q2 expo Authorized Common Stock Shares Limits On Use
AuthorizedCommonStockSharesLimitsOnUse
40000000 shares
CY2013Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
135046000 USD
CY2012Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
134109000 USD
CY2012Q4 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
134149000 USD
CY2013Q3 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne
6069000 USD
CY2013Q3 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo
6357000 USD
CY2013Q3 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year Three
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearThree
873000 USD
CY2013Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
13299000 USD
CY2013Q3 expo Avalable For Sale Securities Short Term Investments Estimated Fair Value Due In Year One
AvalableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne
6066000 USD
CY2013Q3 expo Avalable For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two
AvalableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo
6357000 USD
CY2013Q3 expo Avalable For Sale Securities Short Term Investments Estimated Fair Value Due In Year Three
AvalableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearThree
873000 USD
expo Share Based Compensation Arrangement By Share Based Payment Award Options Expiration Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationTerm
P10Y
CY2011Q2 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
35000000 USD
CY2012Q1 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
35000000 USD
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
35000000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
388604 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
21211000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
404948 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
19437000 USD
us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
34800000 USD
expo Treasury Stock Shares Reissued During Period
TreasuryStockSharesReissuedDuringPeriod
282010 shares
expo Treasury Stock Value Reissued During Period
TreasuryStockValueReissuedDuringPeriod
5711000 USD
expo Treasury Stock Shares Reissued During Period
TreasuryStockSharesReissuedDuringPeriod
292316 shares
expo Treasury Stock Value Reissued During Period
TreasuryStockValueReissuedDuringPeriod
7902000 USD
CY2013Q3 expo Deferred Compensation Plan Invested Amounts
DeferredCompensationPlanInvestedAmounts
35499000 USD
CY2012Q4 expo Deferred Compensation Plan Invested Amounts
DeferredCompensationPlanInvestedAmounts
27089000 USD
CY2013Q3 expo Deferred Compensation Plan Vested Amounts Due
DeferredCompensationPlanVestedAmountsDue
35431000 USD
CY2012Q4 expo Deferred Compensation Plan Vested Amounts Due
DeferredCompensationPlanVestedAmountsDue
26984000 USD
CY2013Q3 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
1893000 USD
CY2012Q3 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
1094000 USD
expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
4128000 USD
expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
2027000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
17027000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
16026000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
5807000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
5343000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2013Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
892000 USD
CY2012Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1483000 USD
CY2013Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1283000 USD
CY2012Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1133000 USD

Files In Submission

Name View Source Status
0001144204-13-058283-index-headers.html Edgar Link pending
0001144204-13-058283-index.html Edgar Link pending
0001144204-13-058283.txt Edgar Link pending
0001144204-13-058283-xbrl.zip Edgar Link pending
expo-20130927.xml Edgar Link completed
expo-20130927.xsd Edgar Link pending
expo-20130927_cal.xml Edgar Link unprocessable
expo-20130927_def.xml Edgar Link unprocessable
expo-20130927_lab.xml Edgar Link unprocessable
expo-20130927_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v357813_10q.htm Edgar Link pending
v357813_ex31-1.htm Edgar Link pending
v357813_ex31-2.htm Edgar Link pending
v357813_ex32-1.htm Edgar Link pending
v357813_ex32-2.htm Edgar Link pending